The use of PTH in the treatment of osteoporosis.

Study on the Effect of Alcoholic Extract of Flaxseed and Aerobic Exercise on Osteoporosis Parameters on Ovariectomized Rats

Background & Aims: Osteoporosis is a systemic skeletal disease associated with decreased bone mass and loss of bone tissue structure, resulting in increased susceptibility to fractures. Depending on the etiological factors, the disease may occur in primary (menopausal and aging) and secondary forms. One of the important etiologies of this disease is estrogen deficiency, in which estrogen defici...

Evaluation of relationship between biochemical parameters and osteoporosis in patients with β-thalassemia major

Background: Osteoporosis is one of the late complications of β-Thalassemia major. The pathogenesis of osteoporosis depends on different factors. Ineffectiveness of hematopoiesis is the major factor, and the other factors are defected by hormonal functions or biochemical parameters. Osteoclasts hyperactivity in thalassemia increases the serum receptor activator of nuclear factor Kappa B ligand (...

پاراتورمون نوترکیب و پوکی استخوان:  مقاله مروری

Osteoporosis is a condition characterized with reduced bone density and destruction of the bone structure. The ideal treatment aims to reduce the risk of fracture while improving the density and structure of the bone. Parathormone (PTH) and its main analogue triparatide (rhPTH [1-34]) is a new class of anabolic medications which accelerates the healing process in the fractured bone through impr...

Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis.

ارتباط مابین تراکم استخوان و وضعیت هورمون‌های جنسی در مردان مبتلا به نارسایی مزمن کلیه

   Background and Aim: Patients with Chronic Renal Failure (CRF) are at high risk of renal osteodystrophy, and this condition develops at the early stages of chronic renal failure and covers a spectrum of bone changes such as osteoporosis. Hypogonadism is common among men with CRF. Many of the manifestations of hypogonadism such as bone disease, are also frequently seen among dialysis patients....